Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Operations (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Cash from Operations for 16 consecutive years, with 1307000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 130.57% year-over-year to 1307000.0, compared with a TTM value of 2085000.0 through Sep 2025, down 163.3%, and an annual FY2024 reading of 4202000.0, up 144.65% over the prior year.
  • Cash from Operations was 1307000.0 for Q3 2025 at Rockwell Medical, down from 1844000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4275000.0 in Q3 2024 and bottomed at 12495000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 3085421.05, with a median of 2380000.0 recorded in 2024.
  • The sharpest move saw Cash from Operations plummeted 240.56% in 2023, then skyrocketed 2111.63% in 2024.
  • Year by year, Cash from Operations stood at 9026000.0 in 2021, then soared by 98.76% to 112000.0 in 2022, then soared by 61.61% to 43000.0 in 2023, then surged by 2111.63% to 865000.0 in 2024, then plummeted by 251.1% to 1307000.0 in 2025.
  • Business Quant data shows Cash from Operations for RMTI at 1307000.0 in Q3 2025, 1844000.0 in Q2 2025, and 3487000.0 in Q1 2025.